Glaxosmi. Pharma

{
  "main_header": {
    "sid": 793005,
    "name": "Glaxosmi. Pharma",
    "stock_name": "Glaxosmi. Pharma",
    "full_name": "Glaxosmithkline Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/glaxosmi-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,863.95",
    "chg": 12.1,
    "chgp": "0.42%",
    "dir": 1,
    "prev_price": "2,851.85",
    "mcapval": "48,542.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500660,
    "symbol": "GLAXO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE159A01016",
    "curr_date": "Sep 21, 03:30 PM",
    "curr_time": "18:38 PM",
    "last_traded_at": "Sep 21, 03:30 PM IST",
    "bse_nse_vol": "24.92 k",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glaxosmi-pharma-793005-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-hold-4195165",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/Glaxosmithkline_mojoScore_4195165.png",
        "date": "2026-09-16 10:10:03",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4194189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/Glaxosmithkline_technicaldot_4194189.png",
        "date": "2026-09-16 08:06:59",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other signals suggest a need for vigilance among investors."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-hold-4183310",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/Glaxosmithkline_mojoScore_4183310.png",
        "date": "2026-09-05 10:10:04",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3121.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-hits-new-52-week-high-at-rs31211-4173740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/Glaxosmithkline_priceRelatedfactors_4173740.png",
        "date": "2026-08-28 15:05:26",
        "description": "With a decisive break above Rs 3121.1 on 28 Aug 2026, Glaxosmithkline Pharmaceuticals Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes amid a sustained five-day rally that has propelled the stock up by 7.64%, outpacing its sector and the broader market."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3067.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-hits-new-52-week-high-at-rs306765-4171630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/Glaxosmithkline_priceRelatedfactors_4171630.png",
        "date": "2026-08-27 10:36:01",
        "description": "Surging past its previous peaks, Glaxosmithkline Pharmaceuticals Ltd reached a new 52-week high of Rs 3067.65 on 27 Aug 2026, marking a notable milestone in its price momentum. This advance comes amid a four-day winning streak, delivering a 5.26% gain over this period and outpacing its sector by 0.68% today."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-hold-4168777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/Glaxosmithkline_mojoScore_4168777.png",
        "date": "2026-08-25 10:10:04",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Gains 7.83%: 6 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-gains-783-6-key-factors-driving-the-surge-4165366",
        "imagepath": "",
        "date": "2026-08-22 15:04:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Stock opens at Rs.2,699.80 with modest gains despite Sensex decline</p>\n                    <p><strong>18 Aug:</strong> New 52-week high at Rs.2,918 and intraday high of Rs.2,834.85; Golden Cross formation confirmed</p>\n                    <p><strong>19 Aug:</strong> Further 52-week high at Rs.3,030 with a 5.09% daily gain; sixth consecutive day of gains</p>\n                    <p><strong>20 Aug:</strong> Minor pullback of 1.12% amid broader market recovery</p>\n                    <p><strong>21 Aug:</strong> Week closes at Rs.2,899.60, down 3.35% on the day but maintaining strong weekly gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n    ..."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Rallies 5.09% and Approaches 52-Week High Amid Sustained Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-hits-intraday-high-with-509-surge-4161539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/Glaxosmithkline_priceRelatedfactors_4161539.png",
        "date": "2026-08-19 15:17:29",
        "description": "While the Sensex declined 0.42% on 19 Aug 2026, Glaxosmithkline Pharmaceuticals Ltd surged 5.09%, touching an intraday high of Rs 3,040. This 5.19 percentage-point outperformance over its sector highlights a distinctly stock-specific rally that extends a strong multi-day winning streak."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3030",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-hits-new-52-week-high-at-rs3030-4161306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/Glaxosmithkline_priceRelatedfactors_4161306.png",
        "date": "2026-08-19 10:41:05",
        "description": "After a sustained six-day rally delivering 16.29% returns, Glaxosmithkline Pharmaceuticals Ltd surged to a fresh 52-week high of Rs 3030 on 19 Jun 2026, outpacing its sector by 4.46% on the day. This milestone caps a year-long ascent from a 52-week low of Rs 2088, marking a 45% gain that contrasts with the Sensex’s 5.81% decline over the same period."
      }
    ],
    "total": 5225,
    "sid": "793005",
    "stock_news_url": "https://www.marketsmojo.com/news/glaxosmithkline-pharmaceuticals-793005"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "15-Sep-2026",
      "details": "As per attachment",
      "source": "BSE"
    },
    {
      "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
      "datetime": "15-Sep-2026",
      "details": "Outcome of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Sep-2026",
      "details": "As per attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has declared <strong>570%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Sep 18",
          "dt": "2018-09-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glaxosmithkline Pharmaceuticals Ltd is Rated Hold

2026-09-16 10:10:03

Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-16 08:06:59

Glaxosmithkline Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other signals suggest a need for vigilance among investors.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Hold

2026-09-05 10:10:04

Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3121.1

2026-08-28 15:05:26

With a decisive break above Rs 3121.1 on 28 Aug 2026, Glaxosmithkline Pharmaceuticals Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes amid a sustained five-day rally that has propelled the stock up by 7.64%, outpacing its sector and the broader market.

Read full news article

Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3067.65

2026-08-27 10:36:01

Surging past its previous peaks, Glaxosmithkline Pharmaceuticals Ltd reached a new 52-week high of Rs 3067.65 on 27 Aug 2026, marking a notable milestone in its price momentum. This advance comes amid a four-day winning streak, delivering a 5.26% gain over this period and outpacing its sector by 0.68% today.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Hold

2026-08-25 10:10:04

Glaxosmithkline Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Glaxosmithkline Pharmaceuticals Gains 7.83%: 6 Key Factors Driving the Surge

2026-08-22 15:04:55

Key Events This Week

17 Aug: Stock opens at Rs.2,699.80 with modest gains despite Sensex decline

18 Aug: New 52-week high at Rs.2,918 and intraday high of Rs.2,834.85; Golden Cross formation confirmed

19 Aug: Further 52-week high at Rs.3,030 with a 5.09% daily gain; sixth consecutive day of gains

20 Aug: Minor pullback of 1.12% amid broader market recovery

21 Aug: Week closes at Rs.2,899.60, down 3.35% on the day but maintaining strong weekly gains

...

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Rallies 5.09% and Approaches 52-Week High Amid Sustained Momentum

2026-08-19 15:17:29

While the Sensex declined 0.42% on 19 Aug 2026, Glaxosmithkline Pharmaceuticals Ltd surged 5.09%, touching an intraday high of Rs 3,040. This 5.19 percentage-point outperformance over its sector highlights a distinctly stock-specific rally that extends a strong multi-day winning streak.

Read full news article

Broad-Based Technical Strength Lifts Glaxosmithkline Pharmaceuticals Ltd to 52-Week High of Rs 3030

2026-08-19 10:41:05

After a sustained six-day rally delivering 16.29% returns, Glaxosmithkline Pharmaceuticals Ltd surged to a fresh 52-week high of Rs 3030 on 19 Jun 2026, outpacing its sector by 4.46% on the day. This milestone caps a year-long ascent from a 52-week low of Rs 2088, marking a 45% gain that contrasts with the Sensex’s 5.81% decline over the same period.

Read full news article

View All News